Adalimumab with Methotrexate in Treatment-Naïve Japanese Patients with Rheumatoid Arthritis at Risk of Progressive Structural Joint Damage: A Postmarketing Observational Study

INTRODUCTION: The objective of this study was to evaluate the real-world safety and effectiveness of adalimumab with methotrexate (MTX) in disease-modifying antirheumatic drug (DMARD)- and biologic-naïve Japanese patients with rheumatoid arthritis (RA) at risk of progressive structural joint damage....

Descripción completa

Detalles Bibliográficos
Autores principales: Ito, Yukiko, Hozumi, Kaori, Okada, Yukiko, Kurimoto, Sarina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2017
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5443728/
https://www.ncbi.nlm.nih.gov/pubmed/28364381
http://dx.doi.org/10.1007/s40744-017-0059-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5443728/
https://www.ncbi.nlm.nih.gov/pubmed/28364381
http://dx.doi.org/10.1007/s40744-017-0059-1

Ejemplares similares